Chronic supplementation with shark liver oil for reducing tumor growth and cachexia in walker 256 tumor-bearing rats

Nutrition and Cancer

Volumn 63, Issue 8, 2011, Pages 1307-1315

  Iagher, Fabíola ^a   De Brito Belo, Sérgio Ricardo ^b   Naliwaiko, Katya ^b   Franzói, Andressa MacHado ^b   De Brito, Gleisson Alisson Pereira ^b   Yamazaki, Ricardo Key ^b   Muritiba, Ana Lcia ^b   Muehlmann, Lúis Alexandre ^b   Steffani, Jovani Antonio ^a   Fernandes, Luiz Cláudio ^b  

^a UNIVERSIDADE DO OESTE DE SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COCONUT OIL; GLUCOSE; LACTIC ACID; OMEGA 3 FATTY ACID; SHARK LIVER OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CACHEXIA; CANCER INHIBITION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; LACTATE BLOOD LEVEL; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; NONHUMAN; RAT; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR CELL; TUMOR XENOGRAFT; WALKER CARCINOMA;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD GLUCOSE; BODY WEIGHT; CACHEXIA; CARCINOMA 256, WALKER; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FISH OILS; GLYCEROL; LACTIC ACID; LIPID PEROXIDATION; LIPID PEROXIDES; LIVER GLYCOGEN; MALE; PLANT OILS; RATS; RATS, WISTAR; SHARKS; TRIGLYCERIDES;

EID: 84857256628     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.607540     Document Type: Article

References (62)

1. Argilés JM, López-Soriano FJ, and Busquets S: No.el approaches to the treatment of cachexia. Drug Disco. Today 13, 73-78, 2008.
2. Morley JE, Thomas DR, and Wilson MMG: Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83, 735-743, 2006. (Pubitemid 44713134)
3. Tisdale MJ: Molecular pathways leading to cancer cachexia. Physiology 20, 340-348, 2005. (Pubitemid 41457399)
4. Tisdale MJ: Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition 12, S31-S33, 1996.
5. Argilés JM, Moore-Carrasco R, Fuster G, Busquets S, and López-Soriano FJ: Cancer cachexia: the molecular mechanisms. Int J Biochem Cell Biol 35, 405-409, 2003. (Pubitemid 36140062)
6. Tisdale MJ: Mechanisms of cancer cachexia. Physiol Re. 89, 381-410, 2009.
7. Tisdale MJ: Pathogenesis of cancer cachexia. J Support Oncol 1, 159-168, 2003.
8. Noguchi Y, Makino T, Yoshikawa T, Nomura K, Fukuzawa K, et al. The possible role of TNF-alpha and IL-2 in inducing tumor associated metabolic alterations. Surg Today 26, 36-41, 1996. (Pubitemid 26064357)
9. Constantinou C, Fontes de Oliveira CC, Mintzopoulos D, Busquets S, Kesarwani M, et al. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine of cancer cachexia. Int J MolMed 27, 15-24, 2011.
10. Dumas JF, Goupille C, Julienne CM, Pinault M, Chealier S, et al. Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosis. J Hepatol 54, 320-327, 2011.
11. Mund RC, Pizato N, Bonatto S, Nunes EA, vicenzi T, et al. Decreased tumor growth in Walker 256 tumor-bearing rats chronically supplemented with fish oil involves COX-2 and PGE2 reduction associated with apoptosis and increased peroxidation. Prostaglandins, Leukot Essential Fatty Acids 76, 113-120, 2007. (Pubitemid 46217230)
12. Rao C., Hirose Y, Indranie C, and Reddy BS:Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res 61, 1927-1933, 2001. (Pubitemid 32692009)
13. Wang YW, Field CJ, and Sim JS: Dietary polyunsaturated fatty acids alter lymphocyte subset proportion and proliferation, serum immunoglobulin G concentration, and immune tissue development in chicks. Poult Sci 79, 1741-1748, 2000.
14. Strom SS, Yamamura Y, Forman MR, Pettaway CA, Stephanie L, et al. Saturated fat intake predicts biochemical failure after prostatectomy. Int J Cancer 122, 2581-2585, 2008. (Pubitemid 351590493)
15. Theodoratou E, McNeill G, Cetnarskyj R, Farrington SM, Tenesa A, et al. Dietary fatty acids and colorectal cancer: a case-control study. Am J Epidemiol 166, 181-195, 2007. (Pubitemid 47227288)
16. Cross AJ, Leitzmann MF, Subar AF, Thompson FE, Hollenbeck E, et al. A prospective study of meat and fat intake in relation to small intestinal cancer. Cancer Res 68, 9274-9279, 2008.
17. Sieri S, vittorio Krogh ., and Ferrari P: Dietary fat and breast cancer risk in the European Prospective In.estigation into Cancer and Nutrition. Am J Clin Nutr 88, 1304-1312, 2008.
18. Butler LM, Wang R, Koh WP, Stern MC, Yuan JM, et al. Marine n-3 and saturated fatty acids in relation to risk of colorectal cancer in Singapore Chinese: a prospective study. Int J Cancer 124, 678-686, 2009.
19. Dahm CC, Keogh RH, Lentjes MAH, Spencer EA, Key TJ, et al. Cancer Epidemiol 34, 562-567, 2010.
20. Hallgren B, StallbergG, and Boeryd B: Occurrence synthesis and biological effects of substituted glycerol ethers. Prog Chem Fats Other Lipids 16, 45-58, 1978.
21. Na.arro-Garcia G, Pacheco-Aguilar R,.allejo-Cordova B, Ramirez-Suarez JC, and Bolaños A: Lipid composition of the liver oil of shark species from the Caribbean and Gulf of California waters. J Food Compost Anal 13, 791-798, 2000.
22. Brohult A: Alkoxyglycerols in irradiation treatment. Nature 193, 1304, 1962.
23. Ngwenya BZ and Foster DM: Enhancement of antibody production by lysophosphatidylcholine and alkylglycerol. Proc Soc Exp Biol Med 196, 69-75, 1991.
24. Oh SY and Jadha. LS: Effects of dietary alkylglycerols in lactating rats on immune responses in pups. Pediatr Res 36, 300-305, 1994. (Pubitemid 24256776)
25. Pedrono F, Cheminade C, and Legrand AB: Natural 1-O-alkylglycerols reduced platelet-activating factor-induced released of [3H]-serotonin in rabbit platelets. Prostaglandins Leucot Essent Fatty Acids 71, 19-23, 2004. (Pubitemid 38881241)
26. Belo SRB, Iagher F, Bonatto SJ, Naliwaiko K, Calder PC, et al. Walker- 256 tumor growth is inhibited by the independent or associative chronic ingestion of shark liver oil and fish oil: a response linked by the increment of peritoneal macrophages nitrite production in Wistar rats. Nutr Res 30, 770-776, 2010.
27. Brohult A, Brohult J, and Brohult S: Biochemical effects of alcoxyglycerols and their use in cancer terapy. Acta Chem Scand 24, 730-732, 1970.
28. Brohult A, Brohult J, Brohult S, and Joelsson I: Effect of alkoxyglycerols on the frequency of injuries following radiation therapy for carcinoma of the uterine cervix. Acta Obstet Gynecol Scand 56, 441-448, 1977. (Pubitemid 8248945)
29. BrohultA, Brohult J, Brohult S, and Joelsson I: Reduced mortality in cancer patients after administration of alcoxyglycerols. Acta Obstet Gynecol Scand 65, 779-785, 1986. (Pubitemid 17200794)
30. Krotkiewski M, Przybyszewska M, and Janik P: Cytostatic and cytotoxic effects of alkylglycerols (Ecomer). Med Sci Monit 9, 131-135, 2003.
31. Brohult A, Brohult J, and Brohult S: Regression of tumour growth after administration of alkoxyglycerols. Acta Obstet Gynecol Scand 57, 79-83, 1978. (Pubitemid 8265693)
32. Pedrono F, Martin B, Leduc C, Le Lan J, Saiag B, et al. Natural alkylglycerols restrain growth and metastasis of grafted tumors in mice. Nutr Cancer 48, 64-69, 2004. (Pubitemid 38823547)
33. Engle PC and Jones JB: Anal Biochem 88, 475-484, 1978.
34. Fernandes LC, Carpinelli AR, Hell NS, and Curi R. Impro.ement of cancer cachexia and decrease of Walker 256 tumor growth by insulin administration in rats. Cancer Ther Control 1, 259-268, 1991.
35. Folch J, Lees M, and Stanley GHS: A simple method for isolation and purification of total lipid from animal tissue. J Biol Chem 226, 497-509, 1957.
36. Abushufa R, Reed P, and Weinko.e C: Fatty acids erythrocytes measured by isocratic HPLC. Clin Chem 40, 1707-1712, 1994. (Pubitemid 24273092)
37. Nourooz-Zadeh J, Tajaddini-Sarmadi J, and Wolff SP: Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220, 403-409, 1994.
38. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein dye binding. Anal Biochem 72, 248-254, 1976.
39. Togni ., Ota CCC, Folador A, Tchaiko.ski Júnior O, Aikawa J, et al. Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with n-3 polyunsaturated fatty acids for one generation. Nutr Cancer 46, 52-58, 2003. (Pubitemid 37163291)
40. Pinto JA, Jr., Folador A, Bonatto SJ, Aikawa J, Yamazaki RK, et al. Fish oil supplementation in F1 generation associated with naproxen, clenbuterol, and insulin administration reduce tumor growth and cachexia inWalker 256tumor-bearing rats. J Nutr Biochem 15, 358-365, 2004. (Pubitemid 38639867)
41. Folador A, Hirabara SM, Bonatto SJR, Aikawa J, Yamazaki RK, et al. Effect of fish oil supplementation for 2 generations on changes in macrophage function induced by Walker 256 cancer cachexia in rats. Int J Cancer 120, 344-350, 2006. (Pubitemid 44956844)
42. Marigny K, Pedrono F, Martin-Chouly CAE, Youmine H, Saiag B, et al. Modulation of endothelial permeability by 1-O-alkylglycerols. Acta Physiol Scand 176, 263, 2002.
43. Lewkowicz P, BanasikM, Glowacka E, Lewkowicz N, and Tchorzewski H: Effect of high doses of shark liver oil supplementation on T cell polarization and peripheral blood polymorphonuclear cell function. Pol Merkuriusz Lek 18, 686-692, 2005. (Pubitemid 40942503)
44. SzostakWBand Szostak-Wegierek D: Health properties of shark oil. Przegl Lek 63, 223-226, 2006.
45. Sirianni R, Chimento A, De Luca A, Zolea F, Carpino A, et al. : Inhibition of cyclooxygenase-2 downregulates aromatase activity and decreases proliferation of leydig Tumor Cells.JBiol Chem284, 28905-28916, 2009.
46. Greenhough A, Wallam CA, Hicks DJ, Moorghen M, Williams AC, et al. The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE2 signaling in colorectal adenoma cells. Oncogene 29, 3398-3410, 2010.
47. Ma DWL, Seo J, Switzer KC, Fan Y, McMurray D, et al. n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 15, 700-706, 2004. (Pubitemid 39611369)
48. Berquin IM, Edwards IJ, and Chen YQ: Multitargeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269, 363-377, 2008.
49. Lim K, Han C, Xu L, Isse K, Demetris AJ, et al. Cyclooxygenase-2-derived prostaglandin E2 activates β-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by ?3 polyunsaturated fatty acids. Cancer Res 68, 553-560, 2008. (Pubitemid 351380084)
50. KobayashiN, Barnard RJ,Henning SM, ElashoffD, Reddy ST, et al. Effect of altering dietary ?-6/?-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res 12, 4662-4670, 2006. (Pubitemid 44297819)
51. Hering J, Garrean S, Dekoj TR, Razzak A, Saied A, et al. Inhibition of proliferation by omega-3 fatty acids in chemoresistent pancreatic cells. Ann Surg Oncol 14, 3620-3628, 2007. (Pubitemid 350160123)
52. Tapiero H, Ba GN, Cou.reur P, and Tew KD: Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologiesv Biomed Pharmacother 56, 215-222, 2002. (Pubitemid 35245217)
53. McEntee MF and Whelan J: Dietary polyunsaturated fatty acids and colorectal neoplasia. Biomed Pharmacother 56, 380-387, 2002. (Pubitemid 35238055)
54. Hardman WE, Munoz J, Jr., and Cameron IL: Role of lipid peroxidation and antioxidant enzymes in omega 3 fatty acids induced suppression of breast cancer xenograft growth in mice. Cancer Cell Int 2, 2002.
55. Yin H, Brooks JD, Gao L, Porter NA, and Morrow JD: Identification of no.el autoxidation products of the ?-3 fatty acid eicosapentaenoic acid in vitro and in vi.o. J Biol Chem 282, 29890-29901, 2007. (Pubitemid 350035269)
56. Calder PC: N-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 41, 203-234, 1997. (Pubitemid 27472618)
57. Heymans F, Da Sil.a C, Marrec N, Godfroid JJ, and Castagna M: Alkyl analogs of diacylglycerol as activators of protein kinase C. FEBS Lett 218, 35-40, 1987.
58. Pugliese PT, Jordan K, CederbergH, and Brohult J: Some biological actions of alkylglycerols from shark liver oil. J Altern Complement Med 4, 87-99, 1998. (Pubitemid 128538827)
59. Conesa-Zamora P,Mollinedo F, Corbal?an-Garc?ia S, and Gómez-Fernández JC: A comparative study of the effect of the antineoplastic ether lipid 1- O-octadecyl-2-omethyl-glycero-3-phosphocholine and some homologous compounds on PKCa and PKCe. Biochim Biophys Acta 1686, 110-119, 2005. (Pubitemid 40228991)
60. Teicher BA Williams JI, Takeuchi H, Ara G, Herbst RS, et al. Potential of the aminosterol, squalamine in combination therapy in the rat 13762 mammary carcinoma and the murine Lewis lung carcinoma. Anticancer Res 18, 2567-2573, 1998. (Pubitemid 28386552)
61. Williams JI, Weitman S, Gonzalez CM, Jundt CH, Marty J, et al. Squalamine treatment of human tumors in nu/nu mice enhances platiniumbased chemotherapiesv Clin Cancer Res 7, 724-733, 2001. (Pubitemid 32707999)
62. Lewkowicz N, Lewkowicz, P, Kurnatowska A, and Tchorzewski H: Biological action and clinical application of shark liver oil. Pol Merkuriusz Lek 20, 598-601, 2006. (Pubitemid 43806007)